Globe Life (NYSE: GL) is one of 40 public companies in the “Life insurance” industry, but how does it weigh in compared to its rivals? We will compare Globe Life to similar companies based on the strength of its profitability, valuation, risk, earnings, dividends, institutional ownership and analyst recommendations.
Risk and Volatility
Globe Life has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, Globe Life’s rivals have a beta of 0.93, meaning that their average share price is 7% less volatile than the S&P 500.
75.6% of Globe Life shares are held by institutional investors. Comparatively, 57.9% of shares of all “Life insurance” companies are held by institutional investors. 3.6% of Globe Life shares are held by company insiders. Comparatively, 10.1% of shares of all “Life insurance” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This table compares Globe Life and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Globe Life Competitors||8.49%||8.39%||1.00%|
Globe Life pays an annual dividend of $0.69 per share and has a dividend yield of 0.7%. Globe Life pays out 11.3% of its earnings in the form of a dividend. As a group, “Life insurance” companies pay a dividend yield of 1.8% and pay out 18.4% of their earnings in the form of a dividend.
This is a breakdown of recent recommendations for Globe Life and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Globe Life Competitors||541||1542||1790||104||2.37|
As a group, “Life insurance” companies have a potential upside of 9.94%. Given Globe Life’s rivals higher possible upside, analysts clearly believe Globe Life has less favorable growth aspects than its rivals.
Valuation and Earnings
This table compares Globe Life and its rivals gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Globe Life||$4.30 billion||$701.47 million||15.51|
|Globe Life Competitors||$18.20 billion||$1.03 billion||13.20|
Globe Life’s rivals have higher revenue and earnings than Globe Life. Globe Life is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Globe Life beats its rivals on 7 of the 12 factors compared.
About Globe Life
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers term life, whole life, children's life, senior life, and family life insurance products; accidental benefits insurance; mortgage protection insurance; and medicare supplement plans. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. is based in McKinney, Texas.
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.